Formoterol/Budesonide + lactose
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Obstructive Airway Disease
Conditions
Obstructive Airway Disease
Trial Timeline
Mar 1, 2008 → Jul 1, 2012
NCT ID
NCT00624754About Formoterol/Budesonide + lactose
Formoterol/Budesonide + lactose is a phase 2 stage product being developed by AstraZeneca for Obstructive Airway Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00624754. Target conditions include Obstructive Airway Disease.
What happened to similar drugs?
20 of 20 similar drugs in Obstructive Airway Disease were approved
Approved (20) Terminated (2) Active (0)
✅Arformoterol Tartrate Inhalation Solution + Arformoterol Tartrate Inhalation Solution + PlaceboSumitomo PharmaApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00624754 | Phase 2 | Completed |
Competing Products
20 competing products in Obstructive Airway Disease